Literature DB >> 3719479

Treatment of breast cancer: what are the trends in 1986?

R Ghys.   

Abstract

Entities:  

Mesh:

Year:  1986        PMID: 3719479      PMCID: PMC1491110     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  A new combined approach to the conservative treatment of early breast cancer.

Authors:  J L Hayward; P J Winter; D Tong; R D Rubens; J G Payne; M A Chaudary; F Habibollahi
Journal:  Surgery       Date:  1984-03       Impact factor: 3.982

2.  Limited surgery and radiotherapy for early breast cancer.

Authors:  J R Harris; S Hellman; D W Kinne
Journal:  N Engl J Med       Date:  1985-11-21       Impact factor: 91.245

3.  Estrogen receptors and response to endocrine therapy and cytotoxic chemotherapy in advanced breast cancer.

Authors:  R D Rubens; J L Hayward
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

4.  Radiation therapy in the management of primary breast cancer.

Authors:  B Pierquin; F Baillet; J F Wilson
Journal:  AJR Am J Roentgenol       Date:  1976-10       Impact factor: 3.959

5.  Conservation surgery and radiation therapy in the treatment of operable breast cancer.

Authors:  E D Montague
Journal:  Cancer       Date:  1984-02-01       Impact factor: 6.860

6.  Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast.

Authors:  J W Meakin; W E Allt; F A Beale; R S Bush; R M Clark; P J Fitzpatrick; N V Hawkins; R D Jenkin; J F Pringle; J G Reid
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

7.  Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer.

Authors:  B Fisher; M Bauer; R Margolese; R Poisson; Y Pilch; C Redmond; E Fisher; N Wolmark; M Deutsch; E Montague
Journal:  N Engl J Med       Date:  1985-03-14       Impact factor: 91.245

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.